Compare HIMS & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HIMS | PLXS |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | Medical/Nursing Services | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 6.7B |
| IPO Year | 2019 | 1995 |
| Metric | HIMS | PLXS |
|---|---|---|
| Price | $32.78 | $252.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $30.46 | ★ $206.50 |
| AVG Volume (30 Days) | ★ 14.8M | 264.4K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 3.32 |
| Revenue | ★ $2,347,637,000.00 | N/A |
| Revenue This Year | $19.82 | $14.31 |
| Revenue Next Year | $19.23 | $8.29 |
| P/E Ratio | ★ N/A | $76.08 |
| Revenue Growth | ★ 59.00 | N/A |
| 52 Week Low | $13.74 | $115.83 |
| 52 Week High | $70.43 | $307.06 |
| Indicator | HIMS | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 48.73 | 39.00 |
| Support Level | $29.39 | $239.59 |
| Resistance Level | $36.22 | $300.15 |
| Average True Range (ATR) | 2.35 | 12.30 |
| MACD | -0.62 | -3.56 |
| Stochastic Oscillator | 15.90 | 22.33 |
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.